ABG Sundal Collier

Vitrolife AB (publ) har slutfört förvärvet av eFertility (STB Zorg B.V.) som tidigare annonserades i pressmeddelande den 2 maj 2024.
eFertili...

Vitrolife AB (publ) today signed an agreement to acquire 100% of the shares in eFertility (STB Zorg B.V.). This acquisition is a key element of th...

At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided:
Resolution in accordance w...

First quarter
Sales of SEK 841 (854) million, a flat growth in local currencies and a decrease of 2% in SEK.
Sales per region, in lo...

The correction concerns a clarification in the agenda that item 13 of the agenda also covers the election of an auditor.
The shareholders of ...

Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q1, 2024. The presentation will be held in E...

Vitrolife Group has today published its Annual and Sustainability Report for 2023.
The Annual and Sustainability Report is now available digi...

The shareholders of Vitrolife AB (publ), corporate identity number 556354-3452
(`the Company') are hereby invited to attend the Annual General Me...

Fourth quarter
Sales of SEK 904 (855) million, an increase of 6%. In local currencies the growth was 5%.
Sales, in local currencies ...

Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the fourth quarter and full year report 2023. The presentation ...

· Non-cash impairment of SEK 4.3 billion in the fourth quarter 2023, relating to the impairment of goodwill attributed to the acquisition of Igeno...

Flaggningsmeddelande i Vitrolife AB
Anmälan om förvärv eller överlåtelse av finansiella instrument.
Emittent
...

Press the button and be introduced to a new random company!